CN1483422A - Medicine for treating diabetes - Google Patents
Medicine for treating diabetes Download PDFInfo
- Publication number
- CN1483422A CN1483422A CNA021312494A CN02131249A CN1483422A CN 1483422 A CN1483422 A CN 1483422A CN A021312494 A CNA021312494 A CN A021312494A CN 02131249 A CN02131249 A CN 02131249A CN 1483422 A CN1483422 A CN 1483422A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- fructus
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicine for curing diabetes. It is made of 24 Chinese medicinal materials of astragalus root, polygonatum root, ginseng, cornux fruit, notoginseng, lycium berry and others. Said medicine can effectively reduced blood sugar, recover insulin function and reduce complicating disease.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of diabetes, be called multiple that recovering capsule again.
Background technology
Diabetes are clinical common diseases, especially with the middle-aged and elderly people pilosity.The Western medicine blood sugar reducing function is rapid, but side effect is arranged, and takes and with the passing of time produces drug resistance.The Chinese medicine blood sugar reducing function is comparatively slow, but can improve islet function, is expected to reach the purpose of thorough treatment diabetes.Therefore, wish the medicine of the effective treatment of exploitation diabetes from Chinese medicine.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine preparation for the treatment of diabetes.This medicine comprises following component by weight:
Radix Astragali 10-30 Rhizoma Polygonati 10-30 Radix Ginseng 7-22
Fructus Corni 7-22 Radix Notoginseng 10-30 Fructus Lycii 10-30
Herba Catharanthi Rosei 15-45 Folium Nelumbinis 10-30 Herba Potentillae Discoloris 10-30
Radix Rehmanniae Preparata 10-30 Semen Nelumbinis 10-30 Radix Angelicae Sinensis 5-15
Radix Ophiopogonis 12-40 Flos Lonicerae 10-30 Fructus Forsythiae 10-30
Rhizoma Polygonati Odorati 15-45 Cortex Lycii 10-30 Rhizoma Atractylodis 10-30
Radix Salviae Miltiorrhizae 15-45 Radix Scrophulariae 10-30 Endothelium Corneum Gigeriae Galli 10-30
The husky garden 10-30 of Rhizoma Anemarrhenae 10-30 Radix Rehmanniae 10-30.
Preferred group of the present invention becomes:
The Radix Astragali 20 Rhizoma Polygonatis 20 Radix Ginsengs 15
Fructus Corni 15 Radix Notoginseng 20 Fructus Lycii 20
20 Herba Potentillae Discoloris 20 of Herba Catharanthi Rosei 30 Folium Nelumbinis
Radix Rehmanniae Preparata 20 Semen Nelumbinis 20 Radix Angelicae Sinensis 10
Radix Ophiopogonis 25 Flos Lonicerae, 20 Fructus Forsythiaes 20
Rhizoma Polygonati Odorati 30 Cortex Lycii 20 Rhizoma Atractylodis 20
Radix Salviae Miltiorrhizae 30 Radix Scrophulariaes 20 Endothelium Corneum Gigeriae Galli 20
The Rhizoma Anemarrhenae 20 Radix Rehmanniae 20 husky gardens 20.
The preparation method of medicine of the present invention comprises that with described raw material leaching, refining, concentrate drying is adjusted concentration, incapsulates.
Certainly, also can make any dosage form that is suitable for clinical practice by the common method of this area, as powder, liquid preparation, pill etc.
The function of medicine of the present invention and effect:
1, by regulating and suppress the secretion of body of gland hormone, repairs and take the cellular metabolism disorder that the Western medicine blood sugar lowering is caused for a long time, activate the activity of B cell, recover islet function, effectively blood sugar control.
2, by promoting glucose oxidation, decomposition, utilize and the inhibition glyconeogenesis, make blood sugar concentration be lower than renal glucose threshold, control glucose in urine effectively.
3, QI invigorating, spleen invigorating, removing food stagnancy, help food, clearing heat and moistening dryness, enriching yin and nourishing kidney, promoting the production of body fluid to quench thirst, the lipoid and reducing blood pressure of dispelling, improving sight and hearing.Strengthen body immunity, recover the elasticity of blood vessel wall, adjust unbalance on the diabetics body on the whole.
Medicine of the present invention is applicable to each diabetes mellitus type of each age group.Particularly effective to II type patient, be better than I type patient.
Embodiment
Embodiment 1
Radix Astragali 20g Rhizoma Polygonati 20g Radix Ginseng 15g
Fructus Corni 15g Radix Notoginseng 20g Fructus Lycii 20g
Herba Catharanthi Rosei 30g Folium Nelumbinis 20g Herba Potentillae Discoloris 20g
Radix Rehmanniae Preparata 20g Semen Nelumbinis 20g Radix Angelicae Sinensis 10g
Radix Ophiopogonis 25g Flos Lonicerae 20g Fructus Forsythiae 20g
Rhizoma Polygonati Odorati 30g Cortex Lycii 20g Rhizoma Atractylodis 20g
Radix Salviae Miltiorrhizae 30g Radix Scrophulariae 20g Endothelium Corneum Gigeriae Galli 20g
The husky garden 20g of Rhizoma Anemarrhenae 20g Radix Rehmanniae 20g
Above-mentioned raw materials is leached, and refining, concentrate drying is adjusted to finite concentration, incapsulates, every capsules 0.25g.
Embodiment 2
Radix Astragali 25g Rhizoma Polygonati 20g Radix Ginseng 10g
Fructus Corni 15g Radix Notoginseng 20g Fructus Lycii 20g
Herba Catharanthi Rosei 30g Folium Nelumbinis 20g Herba Potentillae Discoloris 20g
Radix Rehmanniae Preparata 20g Semen Nelumbinis 20g Radix Angelicae Sinensis 10g
Radix Ophiopogonis 25g Flos Lonicerae 20g Fructus Forsythiae 20g
Rhizoma Polygonati Odorati 40g Cortex Lycii 20g Rhizoma Atractylodis 20g
Radix Salviae Miltiorrhizae 30g Radix Scrophulariae 20g Endothelium Corneum Gigeriae Galli 20g
The husky garden 20g of Rhizoma Anemarrhenae 20g Radix Rehmanniae 25g
Above-mentioned raw materials is leached, and refining, concentrate drying is adjusted to finite concentration, incapsulates, every capsules 0.25g.
The usage of medicine of the present invention and consumption:
Type ii diabetes patient consumption per day is 1-4g, usually about 2.5g, can divide 2-4 time oral, preferably take half an hour after meal.Three months is 1 little course of treatment, and want continuous 3-4 the little course of treatment the full course of treatment.Type i diabetes prolongs according to the state of an illness takes the course of treatment multiplicable in case of necessity taking.Take three week back fasting glucose and reduce to 8mmol/L when following, the consumption of used antidiabetic drug before can reducing subtracts dose for the first time and must not surpass 1/3rd of consumption per day, and when subtracting behind the medicine glucostasis or continuing decline, a Zhou Houke subtracts medicine once more.To continuously and fixedly take, be interrupted.
The curative effect of medicine of the present invention
Medicine of the present invention is a pure Chinese medicinal preparation, and effect relaxes and lasting.After taking for three weeks, " three-many-one-little " symptom has obvious disappearance, and irritated unable symptom alleviates gradually.After taking a little course of treatment, blurred vision, numb twinge, the constipation antiperspirant that overflows, sexual hypofunction take a favorable turn, and blood glucose is progressively reduced to normally, and blood fat, cholesterol all have in various degree and reduce.After taking the full course of treatment, diabetic complication, cardio cerebrovascular affection, diabetic oculopathy, kidney damage etc. take a turn for the better gradually or fully recover.Take through clinical 200 many cases patients, obvious effective rate (blood glucose has obvious reduction, and symptom is obviously improved) is that effective percentage reaches 100% more than 83%.
Claims (3)
1, a kind of medicine for the treatment of diabetes is characterized in that comprising following component by weight:
Radix Astragali 10-30 Rhizoma Polygonati 10-30 Radix Ginseng 7-22
Fructus Corni 7-22 Radix Notoginseng 10-30 Fructus Lycii 10-30
Herba Catharanthi Rosei 15-45 Folium Nelumbinis 10-30 Herba Potentillae Discoloris 10-30
Radix Rehmanniae Preparata 10-30 Semen Nelumbinis 10-30 Radix Angelicae Sinensis 5-15
Radix Ophiopogonis 12-40 Flos Lonicerae 10-30 Fructus Forsythiae 10-30
Rhizoma Polygonati Odorati 15-45 Cortex Lycii 10-30 Rhizoma Atractylodis 10-30
Radix Salviae Miltiorrhizae 15-45 Radix Scrophulariae 10-30 Endothelium Corneum Gigeriae Galli 10-30
The husky garden 10-30 of Rhizoma Anemarrhenae 10-30 Radix Rehmanniae 10-30.
2, the medicine of claim 1 is characterized in that the ratio of each component is:
The Radix Astragali 20 Rhizoma Polygonatis 20 Radix Ginsengs 15
Fructus Corni 15 Radix Notoginseng 20 Fructus Lycii 20
20 Herba Potentillae Discoloris 20 of Herba Catharanthi Rosei 30 Folium Nelumbinis
Radix Rehmanniae Preparata 20 Semen Nelumbinis 20 Radix Angelicae Sinensis 10
Radix Ophiopogonis 25 Flos Lonicerae, 20 Fructus Forsythiaes 20
Rhizoma Polygonati Odorati 30 Cortex Lycii 20 Rhizoma Atractylodis 20
Radix Salviae Miltiorrhizae 30 Radix Scrophulariaes 20 Endothelium Corneum Gigeriae Galli 20
The Rhizoma Anemarrhenae 20 Radix Rehmanniae 20 husky gardens 20.
3, the preparation method of claim 1 or 2 medicine comprises described raw material is leached that refining, concentrate drying is adjusted to debita spissitudo, incapsulates.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02131249 CN1230190C (en) | 2002-09-19 | 2002-09-19 | Medicine for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02131249 CN1230190C (en) | 2002-09-19 | 2002-09-19 | Medicine for treating diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1483422A true CN1483422A (en) | 2004-03-24 |
| CN1230190C CN1230190C (en) | 2005-12-07 |
Family
ID=34144855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02131249 Expired - Fee Related CN1230190C (en) | 2002-09-19 | 2002-09-19 | Medicine for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1230190C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101695543B (en) * | 2009-09-23 | 2011-08-10 | 苏州派腾生物医药科技有限公司 | Composition for treating arrhythmia and preparation method thereof |
| CN101057675B (en) * | 2006-04-19 | 2012-01-04 | 天津开发区太人生物科技有限公司 | Health-care food capable of auxiliary reducing blood sugar and its preparing process |
| CN102526537A (en) * | 2012-03-19 | 2012-07-04 | 常熟华港制药有限公司 | Medicinal composition for treating hyperglycemia |
| CN102716276A (en) * | 2011-06-20 | 2012-10-10 | 王长锋 | Medicine for oral use for treating diabetes |
| CN103356885A (en) * | 2013-08-09 | 2013-10-23 | 李春华 | Medicine for treating diabetes |
| CN106177416A (en) * | 2016-08-24 | 2016-12-07 | 楚雄医药高等专科学校 | A kind of traditional Chinese medicinal composition with effect of reducing blood sugar and preparation method thereof |
| CN113796437A (en) * | 2021-10-28 | 2021-12-17 | 湖北昱安中医康疗有限公司 | Health-care medicinal tea suitable for treating diabetes, use method and application thereof |
-
2002
- 2002-09-19 CN CN 02131249 patent/CN1230190C/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101057675B (en) * | 2006-04-19 | 2012-01-04 | 天津开发区太人生物科技有限公司 | Health-care food capable of auxiliary reducing blood sugar and its preparing process |
| CN101695543B (en) * | 2009-09-23 | 2011-08-10 | 苏州派腾生物医药科技有限公司 | Composition for treating arrhythmia and preparation method thereof |
| CN102716276A (en) * | 2011-06-20 | 2012-10-10 | 王长锋 | Medicine for oral use for treating diabetes |
| CN102716276B (en) * | 2011-06-20 | 2014-06-25 | 王长锋 | Medicine for oral use for treating diabetes |
| CN102526537A (en) * | 2012-03-19 | 2012-07-04 | 常熟华港制药有限公司 | Medicinal composition for treating hyperglycemia |
| CN103356885A (en) * | 2013-08-09 | 2013-10-23 | 李春华 | Medicine for treating diabetes |
| CN106177416A (en) * | 2016-08-24 | 2016-12-07 | 楚雄医药高等专科学校 | A kind of traditional Chinese medicinal composition with effect of reducing blood sugar and preparation method thereof |
| CN106177416B (en) * | 2016-08-24 | 2019-05-10 | 楚雄医药高等专科学校 | A kind of traditional Chinese medicinal composition with effect of reducing blood sugar and preparation method thereof |
| CN113796437A (en) * | 2021-10-28 | 2021-12-17 | 湖北昱安中医康疗有限公司 | Health-care medicinal tea suitable for treating diabetes, use method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1230190C (en) | 2005-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1305844A (en) | Medicine for treating congestive heart failure | |
| CN1132643A (en) | Medicine for diseases of liver and gall | |
| CN1742939A (en) | Medicine for treating pulmonary fibrosis and preparing method | |
| CN1151800C (en) | Medicine for curing diabetic peripheral neuropathy | |
| CN101940716A (en) | Medicament for treating diabetic nephropathy | |
| CN101856405B (en) | Medicinal composition for treating type II diabetes mellitus and preparation method thereof | |
| CN1230190C (en) | Medicine for treating diabetes | |
| CN1843446A (en) | Combined matched pharmaceutical for treating irregular menses | |
| CN1054370A (en) | A kind of manufacture method of kidney-tonifying health-care medicament | |
| CN1970021A (en) | Chinese medicine for treating gout and preparation method thereof | |
| CN1055638C (en) | Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method | |
| CN1241624C (en) | Chinese medicine for health care and treating fatty liver | |
| CN1173726C (en) | Medicine for curing malignant turnor and its preparation method | |
| CN1792372A (en) | Traditional Chinese medicine prepn. for treating diabetes | |
| CN1066332C (en) | Hypoglycemic compound capsule | |
| CN1386546A (en) | Capsule 'Yibao Yishou' for elongating life | |
| CN1879783A (en) | A medicine for treating diabetes | |
| CN1202847C (en) | Diabetes treating medicine | |
| CN1285367C (en) | Medicinal preparation for treating diabetes and its preparation method | |
| CN1127344C (en) | Oral pill for curing diabetes and its complication | |
| CN1053111C (en) | Chinese medical composite preparation with such functions as dispelling toxicity, detoxicating, recuperating, health preserving and face nursing | |
| CN1225823A (en) | Chinese medicine for treating diabetes and preparation method therefor | |
| CN1425456A (en) | Nourishing wine for regulating human body balance function | |
| CN1365828A (en) | Medicine for treating diabetes | |
| CN1161136C (en) | Konjaku capsule for treating type-II diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |